Literature DB >> 11409222

Proportional assist ventilation may improve exercise performance in severe chronic obstructive pulmonary disease.

P Hernandez1, F Maltais, A Gursahaney, P Leblanc, S B Gottfried.   

Abstract

PURPOSE: Exercise tolerance is impaired in chronic obstructive pulmonary disease (COPD), in part because of a reduction in ventilatory capacity and excessive dyspnea experienced. The authors reasoned that proportional assist ventilation (PAV), a ventilator mode in which the level of support varies proportionately with patient effort, could be used during exercise to assist ventilation. The purpose of this study was to evaluate the efficacy of PAV to improve exercise endurance and related physiologic parameters in COPD.
METHODS: In 8 patients (age = 62.8 years mean, +/- 6.9 standard deviation) with severe COPD (forced expiratory volume in 1 second = 0.70 +/- 0.21 L) flow, volume, dyspnea, leg fatigue, arterial blood gases, and gas exchange were measured during constant workrate exercise (37 +/- 18 watts; i.e., 80% previously determined maximum oxygen consumption). Crossover exercise trials were performed in random order: while spontaneously breathing through the experimental circuit without assistance (control trial) and with PAV (using 9.8 +/- 2.1 cm H2O/L and 3.3 +/- 1.0 cm H2O/L/sec of volume assist and flow assist, respectively).
RESULTS: The application of PAV during exercise was well tolerated by each subject. Compared with the control measurement at equivalent time during exercise, PAV improved breathing pattern and arterial blood gases while dyspnea was reduced. Consequently, there was a significant increase in exercise duration with PAV (323 +/- 245 seconds during the control trial compared with 507 +/- 334 seconds with PAV, P = 0.02).
CONCLUSIONS: Proportional assist ventilation can improve performance during constant workrate exercise in severe COPD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409222     DOI: 10.1097/00008483-200105000-00003

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  7 in total

1.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

Review 2.  Proportional assist ventilation (PAV): a significant advance or a futile struggle between logic and practice?

Authors:  N Ambrosino; A Rossi
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

3.  Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease.

Authors:  P Hawkins; L C Johnson; D Nikoletou; C-H Hamnegård; R Sherwood; M I Polkey; J Moxham
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

4.  Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease.

Authors:  Fran Dyer; Lizzie Flude; Farid Bazari; Caroline Jolley; Catherine Englebretsen; Dilys Lai; Michael I Polkey; Nicholas S Hopkinson
Journal:  BMC Pulm Med       Date:  2011-12-16       Impact factor: 3.317

5.  Neurally adjusted ventilatory assist and proportional assist ventilation both improve patient-ventilator interaction.

Authors:  Matthieu Schmidt; Felix Kindler; Jérôme Cecchini; Tymothée Poitou; Elise Morawiec; Romain Persichini; Thomas Similowski; Alexandre Demoule
Journal:  Crit Care       Date:  2015-02-25       Impact factor: 9.097

6.  Non invasive ventilation as an additional tool for exercise training.

Authors:  Nicolino Ambrosino; Paolo Cigni
Journal:  Multidiscip Respir Med       Date:  2015-04-09

7.  The Utility and Acceptability of a New Noninvasive Ventilatory Assist Device, Rest-Activity Cycler-Positive Airways Pressure, During Exercise in a Population of Healthy Adults: Cohort Study.

Authors:  Julie Reeve; Sarah Mooney; Nicola Jepsen; David White
Journal:  JMIR Rehabil Assist Technol       Date:  2022-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.